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1. Introduction 
Dietary fiber include fibers from natural sources (such as fruits, vegetables, and wholegrain 
cereals), fibers that are extracted or obtained by other means from food material, and 
synthetic carbohydrate polymers, that have been shown to possess physiological health 
benefits [1, 2]. Dietary fiber can be classified analytically as soluble and insoluble based on 
their solubility in water, but can also be characterized as viscous or non-viscous and 
fermentable or non-fermentable depending upon the physiological characteristics the fiber 
might have [2]. Insoluble dietary fiber includes cellulose, part of hemicellulose, and lignin, 
whereas soluble fibers include components such as pectin, some hemicelluloses, lignin, 
gums and mucilage [2, 3]. Whilst there have been difficulties in achieving a global definition 
for dietary fiber, it is now generally accepted that dietary fiber can be defined as 
carbohydrate polymers with a degree of polymerization of 3 or more monomeric units 
which are not hydrolysed in the small intestine by the endogenous enzymes [4]. As fiber is 
resistant to digestion and absorption in the human small intestine, it enters the colon where 
it can be partially or completely fermented [5].  
Polydextrose is a polysaccharide produced by the random polymerization of glucose in the 
presence of sorbitol and a suitable acid catalyst, at a high temperature and under partial 
vacuum [6]. Polydextrose is composed of a mixture of glucose oligomers, with an average 
degree of polymerization ~12, but ranging from residual monomer to dp >100 [6, 7]. It is a 
branched molecule, and contains all different combinations of α- and β-linked 12, 13, 
14 and 16 glycosidic linkages (Figure 1) [7, 8]. As polydextrose is only partially digested 
during gastrointestinal transit, it acts as a substrate for saccharolytic fermentation 
throughout the colon, even to the distal parts [9-12]. Polydextrose has a low caloric value: 
about 1 kcal/g, and it is widely used as a bulking agent and to replace the structure and 
texture of sucrose in low-calorie products by the food industry in confectionery applications, 
in pastry and bread, in dairy products, meat products, pasta and noodles, and in beverages 
[7, 13]. Polydextrose is widely accepted as a soluble fiber and has scientifically substantiated 
fiber characteristics, including increase in stool weight, decreased transit time, improved 
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stool consistency and ease of defecation, and reduced fecal pH [7]. It is safe to use, and well 
tolerated, with a mean laxative threshold of 90 g/day, or 50 g as a single bolus dose [14-16].  
 
Figure 1. Structure for the polydextrose. The letter R can be either hydrogen (H), sorbitol, sorbitol 
bridge, of more polydextrose. Polydextrose has highly branched complex three-dimensional structure 
with all different combinations of α- and β-linked 12, 13, 14 and 16 glycosidic linkages. 
Several beneficial effects have been linked to the consumption of polydextrose. 
Consumption of polydextrose promotes the growth of beneficial bifidobacteria and 
lactobacilli while preventing the growth of harmful ones, such as clostridia [17, 18]. It has 
been suggested to possess anti-inflammatory actions and to improve the signs of 
osteoarthritis in canines [19], to increase IgA amount in the rat cecum [20], to reduce cyclo-
oxygenase 2 expression in pigs distal colon, and to reduce lesions in rat colitis model [21]. 
Furthermore, it has been suggested to improve the absorption of magnesium, calcium [22-
25] and iron [26]. 
Soluble fiber, both viscous (e.g. gums, pectin and β-glucan) and non-viscous (e.g. 
polydextrose, resistant maltodextrin and inulin), has been suggested to have beneficial 
metabolic advantages. These include increasing satiety and reduction of body weight, 
control of postprandial glycemic and insulin responses, and hypocholesterolemic effects on 
serum lipid parameters [5, 27]. The inverse relationship of higher HDL to coronary artery 
disease risk has been recognized and is evident across numerous populations, and the 
increment of its relative amount over LDL has been generally accepted as a hallmark of 
better cardiovascular health [28]. Soluble fiber has been associated inversely with serum 
total and LDL cholesterol, while HDL cholesterol concentration has been reported to either 
slightly decrease or remain unchanged [29, 30]. This effect has been attributed as an effect of 
soluble viscous fibers, as insoluble fibers do not appear to affect serum cholesterol 
concentrations [31, 32]. The ability of soluble fibers to reduce serum triglyceride levels is also 
controversial, as in some studies an inverse association has been suggested, while in many 
studies no effect has been observed [29, 33]. Soluble viscous fibers have a characteristic of 
being hypocholesterolemic, reducing serum cholesterol by about 5-10 % for a 5-10 g dose in 
subjects with hypercholesterolemia, whereas insoluble fibers have not shown this effect [34].  
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2. Polydextrose studies in animals, human and in vitro: Contribution of 
polydextrose in lipid metabolism 
Polydextrose is a fermentable non-viscous fiber, and has been shown to exhibit lipid 
metabolism regulating effects [5]. Typically these effects have been associated with two 
physiochemical properties of soluble fibers: viscosity and fermentability. Viscous soluble 
fibers may work by slowing down gastric emptying and prevention of bile salt re-
absorption which would increase the secretion of bile acids and neutral sterols into feces and 
interruption of the enterohepatic circulation of bile acids [35, 36]. Soluble fiber can also 
decrease intestinal cholesterol absorption by affecting micelle formation and mobility [37, 
38], and reduce glycemic response leading to lower insulin stimulation and hepatic 
cholesterol synthesis [39]. Fibers can also promote satiety [40]. Additionally, colonic 
fermentation products of these fibers, short chain fatty acids (SCFAs), mainly propionate, 
have been shown to inhibit hepatic fatty acid synthesis [41]. Polydextrose has been reported 
to confer lipid modulating effects in human clinical intervention studies, as well as in animal 
studies. However, some of the characteristics of polydextrose are different to other soluble 
fibers, such as low viscosity, and sustained fermentation throughout the colon [11]. 
2.1. Polydextrose studies in animals 
The ability of polydextrose to modulate triglycerides, total, LDL, and HDL cholesterol has 
been studied in animals both in normal diets without additional lipid load or in diets in 
which lipids have been included as part of the normal diet. There is a clear difference 
between the types of studies, as the two studies without lipid load have not shown any 
effect on the blood lipid values. In a 6-week feeding study in normal rats with 5 % (w/w) 
inclusion of polydextrose no change in plasma triglycerides, total cholesterol, and HDL 
cholesterol or liver cholesterol, triglycerides and phospholipids was observed [42]. Another, 
15-day feeding trial with rats, did not show differences in serum total and free cholesterol, 
triacylglycerols, and phospholipids even though 3 % polydextrose was administered 
together with 3 % pectin or 3 % cellulose [43].  
However, in two other rat feeding studies in which polydextrose was accompanied with a 
lipid load, reduced lipid levels were reported. In one study rats were given two different 
dosages of corn oil, 10 % and 20 %, to represent a moderate or high fat diet, for 8 weeks, 
with or without 5 % polydextrose [44]. Rats in the polydextrose group showed decreased 
serum triglycerides as compared to a guar gum control in the high-fat diet, and increased 
levels of serum HDL cholesterol both in the moderate fat and high fat diet [44]. Serum total 
lipids and cholesterol remained at the level of the control [44]. One study has been done 
with gerbils: in the 4-week study the gerbils were fed with 0.15 % cholesterol with 30 % of 
the energy coming from fat and with inclusion of 6 % polydextrose [45]. Both liver and 
plasma total cholesterol as well as free and esterified cholesterol from liver decreased in the 
polydextrose group [45]. The effect was presumed by the authors to be related to the 
reduction of VLDL and LDL, since no change in HDL was observed [45]. In the same gerbil 
study, it was additionally investigated whether polydextrose can remove cholesterol from  
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n.a. not available; d days; w weeks; m months; a↓ ↑ ↓ ↑ reduced;  increased; Trend  or Trend  only a tendency for reduced or increased values were observed; N.C. no 
change 
a Indirect evidence, LDL and VLDL were not directly measured but authors concluded that as total cholesterol decreased and there was no change in HDL, then 
preferential target is then VLDL and/or LDL. 
b 0.4 % cholesterol administered to the gerbils 2 weeks prior the feeding with polydextrose in order to expand the endogenous cholesterol pools.  
c 0.4 % cholesterol administered to the gerbils 2 weeks prior the feeding with polydextrose in order to expand the endogenous cholesterol pools. 
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Study design Cholesterol
Ref Animals Dose Time Lipid load Total LDL HDL TG Remarks
[42] Sprague-Dawley 
rats
5 % 6 w No load N.C. n.a. N.C. N.C. Lipids meas-
ured both from 
plasma and liver
[43] Sprague-Dawley 
rats
3 % 15 d No load N.C. n.a. n.a. N.C. Together with 
pectin or cel-
lulosa
[44] Sprague-Dawley 
rats
5 % 8 w 10 % and 
20 % from 
corn oil
N.C. n.a.   Compared to 
guar gum group
[45] Gerbils 6 % 4 w 30 % en-
ergy from 
fat, 0.15 % 
from cho-
lesterol
  
(or 
VLDL)a
N.C. N.C. Liver total , 
free 
cholesterol 
Total to HDL 
ratio trend  in 
plasma
[45] Gerbils 6 % 3 w 0.4 % 
choleterol 
preloadb
 n.a.  N.C. Liver total , 
-
lesterol 
[46] Wistar rats 28 % as 3 
ml/200 g 
body weight
Acute Fats as in 
chocolate
n.a. n.a. n.a.  Together with 
25.7 % lactitol
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endogenous pools by first artificially expanding the endogenous cholesterol pools of the 
gerbils with a preload of 0.4 % cholesterol for two weeks before 6 % polydextrose was fed 
for an additional three weeks. Polydextrose was shown to hasten the endogenous clearance 
of cholesterol pools, and to reduce liver and plasma total cholesterol, esterified cholesterol 
from liver and plasma HDL cholesterol [45].  
The acute response of polydextrose on serum lipid values has also been studied in rats, but 
together with lactitol [46]. Polydextrose was administered as a 28 % solution in a dose of 3 
ml/200 g of body weight in a solution also containing 26 % lactitol and a fat emulsion which 
was comparable to one in chocolate. The rats showed reduced serum triglyceride levels, and 
an increase in luminal triglyceride levels in the cecum after 150 minutes of ingestion of 
polydextrose, which would indicate that the combination of polydextrose and lactitol 
reduced either the level of fat absorption in the earlier part of small intestine or promoted 
the transit time of fat through the intestine [46]. No change in total, HDL, or LDL cholesterol 
were found in that study.  
These studies are summarised in Table 1. There is an indication from these studies that 
polydextrose can lower total cholesterol and has a tendency to lower LDL cholesterol and 
tendency to increase HDL cholesterol.  
2.2. Polydextrose lipid metabolism studies in clinical intervention studies 
Clinical intervention studies with polydextrose have been conducted either with healthy 
adults, with individuals having hypercholesterolemia or with individuals with impaired 
glucose tolerance.  
In a human study with normal healthy adults with no reported hypercholesterolemia a 
reduction in the amount of total HDL by administration of 15 g of polydextrose for two 
months with concomitant decrease in apolipoprotein A-I, which is the main component of 
the HDL cholesterol, has been observed [47]. Apolipoprotein B levels, found in all 
atherogenic apolipoprotein particles, and the LDL cholesterol levels itself had also a 
tendency to be reduced after the 2-month and 1-month intervention period, respectively 
[47]. In another study with healthy adults, administration of 10 g of polydextrose for 18 days 
was shown to decrease LDL cholesterol and total cholesterol values with no effect on HDL 
cholesterol or triglycerides [48]. There are also contradictory results with healthy humans, as 
administration of polydextrose in an amount from 4 to 12 g per day for 29 days did not 
affect triacylglycerol, or cholesterol [49]. However, in that study no data was shown, and in 
addition to which the cholesterol type measured was not specified.  
In hypercholesterolomic individuals, the effect of polydextrose has been studied in a 4-week 
study with administration of 15 g and 30 g polydextrose daily [45]. The study was quite 
small, with only 12 subjects participating, and each individual subject serving as a control 
for him/herself. In this study it was noted that 5 of the 6 individuals ingesting 30 g of 
polydextrose were in a separate responder group, and in this group the LDL cholesterol 
values declined significantly, and there was a tendency for reduced total cholesterol, but no 
change in HDL cholesterol. However, when all 6 individuals were studied together, no 
change compared to control was observed. 
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In diabetic patients, diets containing high amounts of fiber have improved plasma lipid 
control [50, 51]. The effect of polydextrose on lipid values has been of interest in two studies 
with individuals showing abnormal glucose metabolism or type 2 diabetes. In subjects with 
impaired glucose metabolism, polydextrose administered for 12 weeks at 16 g/day has been 
observed to lower LDL cholesterol, increase HDL cholesterol and cause no change in 
triglycerides [52]. In this study, LDL cholesterol decreased also in the control group 
probably because of simultaneous nutrition consultation by a nutritionist [52]. In a 
combination study with 7 g polydextrose and 3 g oligofructose administered daily for 6 
weeks in adults with type 2 diabetes, a decrease in total cholesterol, triglycerides, VLDL 
cholesterol, and ratios of total cholesterol to HDL cholesterol, and LDL cholesterol to HDL 
cholesterol was observed, while HDL cholesterol increased [53].  
The acute effect of polydextrose has been studied in humans too, together with lactitol, in 
the triglyceride levels after consumption of 46 g of chocolate supplemented with 15.1 % of 
the weight with polydextrose. The intervention group had reduced serum triglycerides in 
comparison to control chocolate during the 150 minutes the triglycerides were measured 
from the blood [46]. During intense exercise, polydextrose has been shown to reduce the 
amount of free fatty acids in plasma [54]. In addition, an abstract has been published about 
ingestion of 12.5 g polydextrose during a hamburger meal observing a reduction in total 
postprandial hypertriglyceridemia by 25 % [55].  
2.2.1. Effect of polydextrose on different HDL subfractions 
HDL is highly heterogeneous, and subfractions of it can be identified on the basis of density, 
size, charge, and protein composition [56]. Different fractions of HDL can be identified by 
ultracentrifugation, gradient gel electrophoresis, and nuclear magnetic resonance (NMR) 
spectroscopy, and these different fractions could play diverse roles in protective function 
[56, 57]. It is thought that certain fractions of HDL cholesterol could be better predictors of 
cardiovascular diseases and its risk. However, controversy about the role of the different 
forms still exists, as in [58] and in [59] increased HDL2 and apoA-I levels were associated as 
protective against coronary heart disease. In other studies, in turn, such as in [60], and [61], 
the HDL3 has had a stronger inverse association with coronary heart disease. The early 
studies, however, more strongly indicate that reduced levels of HDL2 over HDL3 is 
associated more strongly to CVD risk [62].  
The different subfractions of HDL and the impact of ingestion of polydextrose on their 
distribution has been investigated in one study [47], and in this study HDL3 was increased 
during the 2-month intervention period and one month after finishing the study. At the 
same time, a reduced level of HDL2, apoA-I and LCAT activity was observed. In other 
studies with soluble fibers, such as with guar gum, no changes in HDL2 and HDL3 
subfractions or their ratio were observed [63, 64]. No difference between serum HDL2 and 
HDL3 cholesterol subfractions could be observed between high-fiber, consisting partially of 
soluble fiber from psyllium, and low-fiber diets [65] or with beta-glucan as an oat fiber 
extract [66]. In addition, lack of standardization among the analytical methods that are used 
to measure size distribution of different HDL2 and HDL3 subfractions may cause 
approximation of HDL subclass levels [67, 68]. 
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n.a. not available; d days; w weeks; m months; ↓ ↑ ↓ ↑ reduced;  increased; Trend  or Trend  only tendency for reduced or increased values were observed; N.C. no 
change 
a had a tendency to be reduced 1 month after intervention 
b Total cholesterol and LDL cholesterol were reduced by 6 % but not significantly 
c When studied form a group that responded to the 30 daily dose of polydextrose 
d Both in the responder group that ingested 30g/day polydextrose and in a group in which in addition to responders, a non-responder was included. 
T
a
b
le
 2
. P
o
ly
d
ex
tro
se clin
ical in
terv
en
tio
n
 stu
d
ies in
 w
h
ich
 lip
id
 v
alu
es h
av
e b
een
 m
easu
red
. 
Study design Cholesterol
Ref Dose Time Lipid load Total LDL HDL TG Remarks
[47] Healthy 15 g/day 2 m N.C. N.C.a HDL2
HDL3
N.C.a ApoA-I 
ApoA-II 
[69] Healthy 15 g/day 4 w Trendb Trendb N.C. N.C. ApoB 
[48] Healthy 10 g/day 18 d   N.C. N.C.
[49] Healthy 4, 8, or 12 g/
day
28 d N.C. N.C. N.C. N.C. Measured lipid 
values were not 
[46] Healthy 15.1 % in 46 g 
of chololate
Acute Lipids 
from 
chocolate
n.a. n.a. n.a.  Together with 
19.4 % lactitol
[45] With hypercholes-
terolemia
15 or 30 g/
day
4 w Trend c c N.C.d N.C.d
[52] With impaired glu-
cose metabolism
16 g/day 12 w N.C.   N.C. Total to HDL 
ratio 
[53] With type 2 dia-
betes
13.2 g/day 6 w     With 6.8 g oli-
gofructose/day.  
Total/HDL cho-
lesterol ,
VLDL choles-
terol 
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Table 2 summarizes the different human clinical intervention studies done with 
polydextrose in relation to HDL, LDL, total cholesterol and triglycerides. From these studies 
it can be concluded that polydextrose in the diet can lower serum total and LDL cholesterol 
and triglycerides. There are two studies in which definite increases in HDL have been 
observed. 
3. Mechanisms for polydextrose action on lipid values 
3.1. Role of polydextrose in enterohepatic bile circulation and in cholesterol 
absorption  
One of the mechanisms by which soluble viscous fibers induce hypocholesterolemic 
responses is the disruption of enterohepatic bile acid circulation, which reduces absorption 
of intestinal bile acids. The major route by which cholesterol in the liver is eliminated is 
through the de novo synthesis of primary bile acids from cholesterol [70]. The bile is 
released into the small intestine, where bile salt micelles help in the solubilisation of 
lipophilic components, such as cholesterol, fat soluble vitamins, and other lipids [70]. The 
diffusion of the micelles with solubilised components as well as the biliary and dietary 
cholesterol across the unstirred water layer, covering the luminal side of the enterocytes 
facilitate the uptake of cholesterol and other lipophilic components by the enterocytes [71]. 
When the bile salt micelles have accomplished their role they transit the remainder of small 
and large intestine where they are progressively absorbed into the enterohepatic circulation 
by the hepatic portal vein [70]. The bile salts that escape the intestinal absorption are 
transformed through colonic bacterial enzymatic activity to form secondary bile salts, from 
which deoxycholic acid is absorbed passively through colonic epithelium into the 
enterohepatic circulation, while lithocholic acid is secreted into the feces [72]. The amount of 
bile salts, both primary and secondary, is maintained in a rather constant level, and the daily 
bile salt losses are compensated by de novo hepatic biosynthesis [73]. The enterohepatic 
circulation is very efficient, as 95 % of the bile salts released into the intestine is absorbed 
back to the liver [70].  
The presence of viscous soluble fiber has been shown to prevent bile salt reabsorption, 
which leads to enhanced excretion of bile salts into feces [35, 36]. This depletes the bile acids 
from liver and leads to rapid catabolisation of cholesterol through activation of 7alpha-
hydroxylase. At the same time cholesteryl esters are metabolised, and in order to replace 
these production of LDL surface membrane receptors and concomitant LDL cholesterol 
uptake from blood stream are increased. This leads to lowering of the blood cholesterol 
concentration [74]. The fibers presumably interact with bile acids directly at the molecular 
level or entrap bile salt micelles in the gelatinous network formed by the polymeric fiber [35, 
75]. The fiber can also form a barrier which can prevent the formation of bile acid micelles, 
and increase the unstirred water layer lining the intestinal mucosal surface [76].  
Polydextrose is a non-viscous fiber and its capacity to bind bile salts has been studied in one 
clinical intervention study [77]. In this study, administration of polydextrose in healthy 
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adults at 8 g/day for three weeks was not found to increase fecal excretion of total bile acids 
and secondary bile acids, but rather decreased values were observed during the intervention 
period compared to the run-in period before [77]. A similar observation was made in normal 
rats, in which administration of 5 % polydextrose for 6 weeks did not increase the fecal 
output of bile acids [42]. The low ability of polydextrose to bind bile acids is not, however, 
surprising. In order for a fiber to bind bile acids, it is required to be viscous in nature, and 
polydextrose is lower in viscosity for instance in comparison to pectin and guar gum which 
have high water binding capacity with higher viscosity and thus increased capability to bind 
bile acids [42, 78]. Polydextrose has a high capacity to bind water, and it can for instance 
relieve constipation presumably due to this characteristic, but there is no gel formation by 
polydextrose in water and little viscosity [43, 79, 80].  
Even though no clear effect on bile acid binding can be detected, the fact that cholesterol and 
triglyceride absorption can still be modulated, are indications that polydextrose can retard 
the transportation of lipids from the intestinal lumen to the lymph. When polydextrose was 
infused as 5 % and 10 % to duodenum together with cholesterol and triglyceride on 
mesenteric lymph-fistulated rats, the amount of cholesterol and triglycerides in the lymph 
decreased dose-dependently, and concomitantly the amount of the unabsorbed lipids 
increased in the lumen of the intestine [81]. It was concluded that since most of the luminal 
triglyceride and cholesterol was detected in the proximal part of the small intestine, the 
absorption of the lipids was inhibited. There was a tendency to have increased amount of 
cholesterol and a significant increase of triglycerides remaining in the colon which could 
indicate that some of the lipids were not absorbed [81]. However, polydextrose did not seem 
to increase secretion of cholesterol into feces in rats even though some tendency was 
observed in another study [82]. 
In an acute response study of polydextrose in combination with lactitol in rats with  
lipid load similar to the composition of chocolate an increase in luminal triglyceride in the 
cecum was observed with concomitant decrease in serum triglycerides [46]. This would 
indicate that the combination of polydextrose and lactitol reduced either the level of fat 
absorption in the earlier part of small intestine or promoted the transit time of fat through 
the intestine [46].  
Cholesterol that escapes absorption is partially degraded to coprostanol and coprostanone 
by colon microbes [83]. A decrease of the degradation products coprostanol, coprostanon 
and cholestanol has been observed [77] which would indicate that the amount of cholesterol 
entering the colon is less in humans receiving polydextrose.  
3.2. Role of polydextrose on intestinal microbiota and its impact on cholesterol 
metabolism 
When soluble fiber enters the large intestine, it is fermented by the residual microbes 
forming short-chain fatty acids (SCFAs), butyrate, acetate, and propionate, end-products of 
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bacterial carbohydrate fermentation. The SCFAs have been indicated to possess different 
physiological functions. Butyrate has been implicated to be the most important SCFA for 
colonic and immune cells due to its ability to serve as energy source for colonic epithelium 
as well as regulate cell growth and differentiation [84, 85]. It is a preferred energy source by 
colonocytes over glucose, glutamine, or other SCFA, and 70 to 90 % of butyrate is 
metabolized by colonocytes [86]. It has been implicated to inhibit intestinal cholesterol 
biosynthesis [87]. Acetate, as a direct substrate for acetyl-CoA synthetase, an enzyme that 
converts acetate to acetyl-CoA for entering to the cholesterol and fatty acid synthesis cycle, 
has been implicated to increase liver cholesterol, and fatty acid levels [41, 88]. Acetate has 
been shown to associate negatively with visceral adipose tissues and insulin levels in obese 
people [89]. Propionate has been shown to possess antilipogenic and cholesterol-lowering 
effects. While acetate is a substrate for sterol and fatty acid synthesis, propionate counteracts 
this by inhibiting acetate incorporation to serum lipids [41]. Propionate has been shown to to 
reduce the rate of cholesterol synthesis [87, 90], to inhibit fatty acid synthesis [91], to 
decrease liver lipogenesis [92], and to decrease hepatic and plasma and serum cholesterol 
levels [93, 94]. Propionate supplementation has been shown increase serum HDL cholesterol 
and triglyceride levels without effect on total cholesterol [92, 95]. However, contradictory 
results about its efficacy on cholesterol metabolism has been also observed [96-98]. 
The production of short-chain fatty acids during polydextrose fermentation has been 
studied with batch fermentations, colon simulators as well as from feces in animal and 
human studies. The differences in the results reflect individual variation, sampling, and 
differences in the methods used. Fecal SCFA concentration measurements are not the best 
indicators of SCFA produced as the majority of fecal SCFA is absorbed rapidly by the 
colonic epithelial cells [99]. Polydextrose has been observed to increase the production of 
butyrate, acetate and propionate in vitro [18, 100-102], in rats [20], pigs [11], in dogs [103] 
and in humans [17, 49]. When compared to other fibers, polydextrose produced similar 
quantities of SCFAs, and the molecular ratio of acetate/propionate/butyrate produced was 
found to be similar to that of fructo-oligosaccharides and xylo-oligosaccharides and other 
carbohydrates, such as inulin, pectin, and arabinose [104, 105] while in other studies 
polydextrose produced less total SCFAs compared to FOS, inulin and GOS [102, 106, 107]. 
The lower production of SCFAs by polydextrose can be explained by the lower digestability 
of polydextrose and its more sustained fermentation throughout the gut due to its branched 
complex structure. Furthermore, polydextrose fermentation has been shown to reduce 
putrefactive microbial metabolites, or branched-chain fatty acids and biogenic amines 
produced from protein fermentation [11, 20, 49, 100, 101, 107-109] but the decrease of these 
in relation to lipid metabolism and absorption is unknown. Figure 2 shows an example of 
how fermentation of polydextrose increases the amount short chain fatty acids in an in vitro 
colon simulation both when the amount of polydextrose is increased, and when the 
simulation proceeds from vessel V1 representing proximal part of the colon towards the 
vessels representing more distal parts of the colon [108]. 
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Figure 2. Concentration (mM) of short chain fatty acids (SCFAs) in the different vessels V1, V2, V3, and 
V4 after 48h in vitro colon fermentation simulation. An increase in the concentration of SCFAs can be 
observed both dose-dependently as well as from vessels representing proximal colon V1 towards 
vessels representing more distal parts of the colon, V3 and V4.  
When polydextrose enters the colon, it is fermented by the indigenous microbiota, thus 
serving as an energy-source to promote their growth and survival. In germ-free mice, the 
transplantation of the colonic microbiota from normal mice resulted in a 60 % increase in 
body fat in an unchanged diet [110] and there are an increasing number of reports that the 
gut microbiota may play an important role in cholesterol and lipid homeostasis, in obesity 
and metabolic syndrome [111-113].  
Bacterial DNA of fecal samples from 20 individuals consuming 21 g of polydextrose in 3 
doses per day were pyrosequenced, and the amount of Clostridiaceae, and Veillonea 
increased while Lachnospiraeae and Eubacteriaceae decreased compared to the control 
group without additional supplemental fiber [114]. Well-known butyrate-producers were 
increased in number, such as Faecalibacterium, and especially Faecalibacterium prausnitzii, 
whereas other SCFA producers, such as Lachnospiraceae, and Eubacteriaceae were reduced 
in number by administration of polydextrose [114]. Polydextrose also decreased the number 
of Coriobacteriaceae, which have been shown to have a positive association to non-HDL 
cholesterol [111, 114]. Interestingly, bifidobacteria have shown a positive correlation with 
HDL-cholesterol [111], but the bifidobacterial counts were decreased by polydextrose when 
studied with pyrosequencing [114]. In other studies polydextrose administration has been 
shown to increase the amount of bifidobacteria and lactobacilli [17, 18, 49, 106, 107, 115] 
while in some studies this effect has not been noted [103] or that there was no effect on the 
growth of lactobacilli [102]. This kind of inconsistency in the response could reflect the 
interindividual differences in indigenous microbiota to begin with. These kind of 
fluctuations in the indigenous microbiota, however, might explain why there are 
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differencies in the studies with polydextrose and its effect on cholesterol values, for instance 
in [45] in which a responder group with a decrease in LDL was observed.  
3.3. Polydextrose effect on glycemic control and insulin response 
Fibers can affect blood glucose levels by decreasing the glycemic load of a meal or by 
affecting glucose absorption or release of glucose [5], and especially soluble fiber has been 
shown to attenuate the absorption of glucose [27]. Soluble dietary fibers may affect total and 
LDL cholesterol levels through effects on postprandial glycemia, as reduction in the glucose 
absorption, which would lower the insulin level and its production in the pancreas, would 
then lead to a decrease in cholesterol synthesis [116]. When soluble dietary fibers are being 
digested they delay the emptying of digested food from the stomach to the small intestine, 
slow down the transportation and mixing of digestive enzymes in the chyme and increase 
the resistance of the unstirred water layer lining the mucosa [117, 118]. This leads to 
reduction in the absorption of glucose and macronutrients, and lowered level of 
postprandial glucose is accompanied with lowered insulin level which would possibly lead 
to lowered hepatic cholesterol synthesis. [39]. There has been studies describing inverse 
relationship between glycemic load and HDL cholesterol [119, 120], and an indirect 
regulation of intestinal lipid uptake by dietary glucose has been presumed. Short-term 
incubation with intestinal epithelial cells, Caco-2 cells, with glucose on the apical side 
induces a significant uptake of cholesterol in a dose-dependent manner [121], and in 
addition cholesterol synthesis seems to dependent on glucose intake [122]. 
The effect of polydextrose ingestion on glucose and postprandial insulin response has been 
investigated in several studies. Polydextrose has a very low glycemic index (4 to 7) with 
glycemic load of 1 compared to the reference glucose (100) [7, 123]. Polydextrose has been 
reported to attenuate the blood glucose raising potential of glucose, as the glycemic index of 
glucose was reduced from 100 to 88 when 12 grams of polydextrose was ingested together 
with glucose by healthy adults [49]. Similar results were observed in a study with healthy 
adults when 14 g was ingested together with 50 g of glucose or 106 g of bread [124]. Plasma 
glucose levels were decreased by 28 % and 35 %, compared to glucose and bread without 
polydextrose, respectively, with significantly reduced serum insulin levels in the glucose 
plus polydextrose group [124]. These observations indicate that polydextrose could reduce 
the absorption of glucose. When the effect of polydextrose was studied with human subjects 
with impaired glucose tolerance or impaired fasting glucose, no change in plasma glucose or 
insulin has been observed [52]. However, this study [52] had a moderately high fructose 
intake which could have affected the results as fructose does not induce endogenous 
secretion of insulin [125]. Diurnally polydextrose did not seem to change plasma sugar 
levels, but a decrease in insulin after meals was noted [69]. In dogs, polydextrose showed an 
attenuated postprandial glycemic and lower relative insulin responses than the control 
sugar maltitol [126]. 
Polydextrose has been also studied in trials in which the reference group received a normal 
meal/snack with glucose, and the intervention group the same but with the glucose partially 
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replaced with polydextrose. In volunteers with type 2 diabetes, cranberries with 10g of 
polydextrose showed attenuated plasma glucose and insulin response compared to 
cranberries with glucose [127]. In one study with healthy adults, significantly lower 
postprandial glucose levels were observed after ingestion of strawberry jam with 40 % 
polydextrose than after ingestion of strawberry jam sweetened with sugar, corn syrup, or 
apple juice, but this study did not measure insulin [128].  
These above results indicate that polydextrose might have a role in postprandial glucose 
absorption and insulin response. One good candidate to modify insulin response is again 
the SCFAs, especially propionate, which have been shown to improve insulin sensitivity 
during glucose tolerance tests [95]. Polydextrose also might interfere the release and 
absorption of the glucose in the small intestine which would lead to slower and lower blood 
sugar rise [5]. In some of these studies the response is observed because polydextrose was 
used as sugar substitute to lower the caloric content of the snack/product [127, 128]. In [127] 
the beneficial insulin reduction was observed not to be in 1:1 ratio with caloric reduction so 
there might be additional beneficial effect apart from lowering the overall calorie content. 
3.4. Polydextrose as a satiety increasing agent 
Meals dense in fiber have also been demonstrated to be able to control the sense of hunger, 
satiety, inhibit the desire for another meal, or induce satiation, limit the size of the meal, 
possibly by lowering caloric density or slowing down gastric emptying [40, 129] This would 
further decrease the sugar load of the individual, since high-fiber diets usually have a lower 
glycemic load.  
Polydextrose has been observed to significantly reduce the feeling of hunger in subjects with 
impaired glucose metabolism [52], and to have tendency towards reduced snacking [10]. It 
has been shown to increase satiety and to reduce food intake when combined with yoghurt 
preloads [130]. However, evidence has been conflicting - in one study when 25 g 
polydextrose was preloaded in two servings before lunch, no difference in the desire to eat, 
sense of hunger and fullness was observed beween polydextrose and the other fibers tested 
[131]. In this study polydextrose did not decrease the energy consumed in lunch. In another 
study when polydextrose was consumed as 9.5 g in a muffin no difference in the feeling of 
hungriness or food intake was observed between polydextrose and the other fibers studied 
[132]. In the two most recent studies, polydextrose intake of 12 g in a fruit smoothie, 
consumed as a single dose preload, significantly reduced the intake of energy in a buffet 
lunch 1 hour after the consumption of the smoothie [133]. Similar observations with a single 
dose of 6.25 g or 12.5 g of polydextrose before a test lunch were also made in another study 
[134, 135].  
Both butyrate and propionate have been shown to induce gut hormones and reduce food 
intake [136]. Propionate has been shown to act as a satiety-inducing agent, with strong 
effects on energy intake and feeding behaviour with significantly greater feeling of fullness 
and lower desire to eat [137, 138]. This could be introduced by the modulation of the colonic 
mucosa secreted peptide hormones that regulate appetite, such as glucagon like peptide -1 
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(GLP-1), peptide YY (PYY), oxyntomodulin, or SCFA receptors, GPR43 or GPR41, which 
have been localized in intestinal enteroendocrine L cells, that are responsible for the 
production of the appetite regulating hormones [139, 140] but whether polydextrose 
ingestion causes changes in these peptide hormones remains to be investigated. 
3.5. Modulation of genes regulating energy metabolism by polydextrose 
fermentation in colon 
Microbial metabolites have been shown to modulate gene expression, for instance butyrate 
acts as a histone deacetylase (HDAC) inhibitor, and affects gene transciption [141]. 
Polydextrose has been shown to increase expression of PPARγ in the colon of mice [142]. 
This has been attributed to be mediated at least by butyrate, which can not only up regulate 
gene expression of PPARγ, but also activate it [143]. When intestinal epithelial cells were 
treated with polydextrose fermentation metabolites, a gene expression signature was 
induced that approached the response of butyrate [144]. In the study [144] 1 or 2 % 
polydextrose was fermented in a four-stage semicontinuous colon simulation model, in 
which each vessel in sequence represents different parts of the colon. Caco-2 cells were 
treated with the polydextrose fermentation metabolites from each vessel, and the idea was 
to analyse gene expression pattern of the Caco-2 cells treated with fermentation metabolome 
representing the whole colon. The weakness of this study was that the cells were not 
differentiated, but were used as a cancer cell model, and that fermentation metabolites 
originated from a fecal sample only from one individual. In the gene ontology analysis of 
this study, enrichment of class "lipid metabolism" by the polydextrose fermentation 
metabolites was noted, which indicated that genes involved in energy metabolism were 
regulated. Indeed, induction of PPARα, PGC-1α, and Lipin 1which are major regulators of 
the metabolism, were observed. Additionally, some PPARα responsive genes were observed 
to be up regulated, such as SORBS1, LPIN1, NPC1, FATP1, HMOX1, and ACSL1 [144].  
In the intestine, activation of PPARα results in the specific induction of genes involved in 
fatty acid uptake, binding, transport, and catabolism. In addition, genes involved in 
triacylglycerol and glycerolipid metabolism have been suggested to function as fatty acid 
sensors, and in nutrient absorption [145, 146]. PGC-1α participates to the regulation of both 
carbohydrate and lipid metabolism, and it has been involved in the adaptation of and 
maintenance of energy homeostais in caloric restriction [147]. Drosophila PGC-1α homolog 
increases mitochondrial gene expression and activity and protects against age-related loss of 
intestinal homeostasis and integrity, and is suggested to extend life span [148]. Lipin 1 is 
induced by PGC-1α in liver and acts to amplify PGC-1α and to activate many of the genes of 
mitochondrial fatty acid oxidative metabolism [149]. Lipin 1 has been associated with 
insulin sensitivity in adipose tissue and liver which indicates that it has a profound role in 
maintaining systemic metabolic homeostasis [150, 151].  
One of the genes regulated by polydextrose fermentation metabolites was Niemann Pick C1 
(NPC1), a significant contributor to plasma HDL cholesterol formation [152]. NPC1 
facilitates the movement of cholesterol to ABCA1, a cholesterol transporter that is located in 
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the basolateral membrane of enterocytes, that is involved in the efflux process of cholesterol 
to circulating HDL particles [153]. Approximately 30 % of the steady-state HDL was 
contributed by the intestinal ABCA1 in mice [154]. In NPC1 deficient cells the HDL 
cholesterol formation is reduced [155]. 
4. Conclusions 
Based on the current research there is clear evidence that polydextrose has the ability to 
attenuate glucose absorption, reduce insulin response and lower blood LDL, total 
cholesterol and triglyceride levels. HDL cholesterol shows a tendency to be increased, but 
this has not been consistently demonstrated in all studies. This kind of ability to increase 
HDL would be quite unique among soluble fermentable fibers. Animal studies also indicate 
that polydextrose could interfere with cholesterol and triglyceride absorption.  
Figure 3 summarises the possible mechanisms of how polydextrose could affect cholesterol 
and lipid metabolism. Polydextrose is used as a bulking agent, and increases the bulk of the 
material that transits along the colon. This can provide a sense of fullness and satiety. The 
effect of polydextrose on bile acid secretion cannot be definitely concluded at this point but 
is unlikely due to its non-viscous characteristic. It seems, that polydextrose attenuates the 
blood glucose raising potential of glucose itself, and the insulin response. Glucose and 
insulin are linked to hepatic de novo cholesterol synthesis, cholesterol absorption and HDL 
formation. The mechanism of the lipid metabolism modulating effect of polydextrose might 
be indirect, through its fermentation by the indigenous microbiota either the luminal or 
mucosal, that at the same time increase SCFA production. The microbiota can affect 
cholesterol degradation, but could also for instance affect chylomicron formation and 
cholesterol absorption. The absorbed SCFAs, propionate and butyrate, are linked to 
diminishing de novo cholesterol synthesis in the liver. Acetate, in contrast, has an opposite 
effect. Whether SCFAs are the molecules exerting the effect of the polydextrose is not 
known. During the fermentation of soluble fibers other metabolites apart from SCFAs are 
formed [156]. The complex structure of polydextrose facilitates its fermentation throughout 
colon. This differentiates it from other fibers which are fermented early in the colon, and it 
serves as an energy source for bacteria throughout the colon, and changes in the 
composition of the microbiota are observed with an increase in butyrate-producing bacteria 
[114]. It is possible that due to its fermentation characteristics the long-term effect on 
microbiota composition might be different to other soluble fibers. The mechanism of 
polydextrose might also be direct, through modulation of surface receptors, but currently 
there is no evidence for this.  
The microarray study has given ideas of how polydextrose fermentation metabolites might 
affect the intestinal tissue. The evidence is, however, at the transcriptional level only, and is 
speculative. Additional studies in the possible regulation of PPARα, PGC1α, Lipin1, NPC1, 
and others by polydextrose is thus needed. In vitro studies could be used for instance to study 
the role of polydextrose fermentation in HDL formation using a differentiated Caco-2 cell 
model which has shown to be good model to study de novo ApoA-I production [157]. 
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Figure 3. Summary of the polydextrose function in lipid metabolism. 
It could be worthwhile to investigate to what extent polydextrose fermentation metabolites 
cause systemic effects for instance in liver, and its de novo cholesterol synthesis, not 
forgetting the role of the intestine. When lipidemic conditions are normal, the liver is the 
most important site of cholesterol biosynthesis, followed by the intestine. Biosynthesis in the 
liver and intestine account for about 15 and 10 %, respectively, in the total amount of 
cholesterol biosynthesis each day [158] [159]. In hypercholesterolemia, when cholesterol 
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biosynthesis is supressed in most organs by fasting, the intestine becomes the major site of 
cholesterol biosynthesis, and its contribution can increase up to 50 %[160, 161]. Mixtures of 
short chain fatty acids have been show to suppress cholesterol synthesis in the rat liver and 
intestine [162], and whether fermentation metabolites from polydextrose can inhibit 
cholesterol biosynthesis in the intestine, or even in the liver, is an open question.  
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